Clinical significance of microbiota changes under the influence of psychotropic drugs. An updated narrative review

A Misera, I Łoniewski, J Palma, M Kulaszyńska… - Frontiers in …, 2023 - frontiersin.org
Relationship between drugs and microbiota is bilateral. Proper composition thus function of
microbiota is a key to some medications used in modern medicine. However, there is also …

Revolutionizing Leishmaniasis Treatment with Cutting Edge Drug Delivery Systems and Nanovaccines: An Updated Review

S Tambe, S Nag, SR Pandya, R Kumar… - ACS Infectious …, 2024 - ACS Publications
Leishmaniasis, one of the most overlooked tropical diseases, is a life-threatening illness
caused by the parasite Leishmania donovani that is prevalent in underdeveloped nations …

Imipramine Administration in Brucella abortus 2308-Infected Mice Restores Hippocampal Serotonin Levels, Muscle Strength, and Mood, and Decreases Spleen CFU …

JL Maldonado-García, G Pérez-Sánchez… - Pharmaceuticals, 2023 - mdpi.com
Brucellosis infection causes non-specific symptoms such as fever, chills, sweating,
headaches, myalgia, arthralgia, anorexia, fatigue, and mood disorders. In mouse models, it …

Classical and innovative drugs for the treatment of Leishmania infections

WJS Mota, BN Guedes, S Jain, JC Cardoso… - Discover Public …, 2024 - Springer
Although among the six most common parasitic diseases, leishmaniasis is considered a
neglected disease, being recognised as a serious public health burden worldwide. This fact …

Vaterite microparticle-loaded methylene blue for photodynamic activity in macrophages infected with Leishmania braziliensis

VLM Marmo, JAR Ambrósio, EP Gonçalves… - Photochemical & …, 2023 - Springer
Calcium carbonate (CaCO3) exhibits a variety of crystalline phases, including the anhydrous
crystalline polymorphs calcite, aragonite, and vaterite. Developing porous calcium …

Liposomal dual delivery systems in visceral leishmaniasis enhance the synergistic effects of combination therapy: A promise for the future

R Hazra, A Kar, SK Mahapatra - Asian Pacific Journal of Tropical …, 2024 - journals.lww.com
Visceral leishmaniasis (VL) is a neglected tropical disease, and this review has summarized
the current treatment scenario and its prospects. It also highlights alternative approaches …

[HTML][HTML] In silico approaches supporting drug repurposing for Leishmaniasis: a scoping review

G Scheiffer, KZA Domingues, D Gorski… - EXCLI …, 2024 - pmc.ncbi.nlm.nih.gov
The shortage of treatment options for leishmaniasis, especially those easy to administer and
viable for deployment in the world's poorest regions, highlights the importance of employing …

A Novel Bioimpedance-Based Detection of Miltefosine Susceptibility Among Clinical Leishmania donovani Isolates of the Indian Subcontinent Exhibiting Resistance …

S Ghosh, S Biswas, S Mukherjee, A Pal… - Frontiers in Cellular …, 2021 - frontiersin.org
The extent of susceptibility towards miltefosine (Mil), amphotericin B (AmpB), and
paromomycin (Paro) was measured among 19 clinical isolates of Leishmania donovani …

[HTML][HTML] Leishmaniasis: A Multifaceted Approach to Diagnosis, Maladies, Drug Repurposing and Way Forward

N Makarani, K Bharadava, A Kaushik, A Dave… - The Microbe, 2025 - Elsevier
More than 20 species of the protozoan parasite Leishmania cause leishmaniasis, a disease
spread by sand flies. The WHO lists leishmaniasis as one of the most ubiquitous neglected …

Activation of TLR-pathway to induce host Th1 immune response against visceral leishmaniasis: Involvement of galactosylated-flavonoids

S Pradhan, D Manna, S Karmakar, MK Singh… - Heliyon, 2022 - cell.com
Immunotherapeutic strategies against visceral leishmaniasis (VL) are pertinent because of
the emergence of resistance against existing chemotherapy, coupled with their toxicity and …